FIBAO
FIBAO is a nonprofit foundation that provides biosanitary research.
- Company typePrivate
- Founded2006
- HeadquartersGranada, Nicaragua
- Headcount101–250
- GTM typeB2B
- OfferingServices
What FIBAO does
FIBAO manages research resources without prejudice to its public-social objectives and end. It has permanently affected its assets to accomplish the purposes of general interest listed in its Statutes, which are subject to the founding will of its creators.
FIBAO firmographics
Firmographics- Name
- FIBAO
- Legal name
- Fundacion para la Investigacion Biosanitaria de Andalucía Oriental
- Website
- https://fibao.es
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- FIBAO is a nonprofit foundation that provides biosanitary research.
- Ownership category
- akta.pro rank
FIBAO industry classification
Industry- Product category
- Biomedical Research Management Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Industry & Sector Research (Syndicated/Custom) (BPAHALAE)
Keywords
Where FIBAO is headquartered
LocationHeadquarters
- HQ city
- Granada
- HQ country
- Nicaragua
- HQ region
- Latin America
Offices5 records
Markets served
FIBAO business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Public funding and grants: FIBAO receives funding from regional government (Junta de Andalucía), national agencies (Instituto de Salud Carlos III), and European funds (FSE+ European Social Fund) for R&D+I activities, research staff contracts, and infrastructure.
- European Social Fund Plus (FSE+) co-financing: Youth employment program co-financed by FSE+ 2021-2027 to combat youth unemployment and support early research careers. Received 1.78 million euros from regional government for hiring 24 young professionals.
- Innovation transfer and licensing: Revenue from licensing protected research results including medical devices, diagnostic methods, and therapies to private companies.
- Clinical trial management services: Administrative, technical and economic advisory services to researchers and sponsors/CROs for clinical trials and observational studies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Standardized salary funding for R&D+I contract program |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
FIBAO product offering
Product offeringCore offering
FIBAO provides integral management of biomedical research across Eastern Andalusia, delivering services that span the full research value chain from discovery to clinical application. Its core offerings include clinical trial and observational study management, innovation and technology transfer, funding opportunity management, methodological and statistical support, HR and economic-administrative administration for researchers, plus specialized GMP infrastructure for advanced therapy medicinal products and an Early Phase Clinical Trials Unit.
Product overview
FIBAO (Fundación para la Investigación Biosanitaria de Andalucía Oriental – Alejandro Otero) is a non-profit foundation providing comprehensive biomedical research management services across Eastern Andalusia. The organization operates as a platform with multiple interconnected service modules: core research management services (clinical trial management, methodological support, economic administration, HR management), a technology transfer portfolio (Ofertas Tecnológicas catalog), and online portals for funding opportunities (Convocatorias) and employment (Ofertas de Empleo). FIBAO serves as the management entity for ibs.GRANADA and supports 17 hospitals, 11 health districts, 3 universities, and over 1,200 researchers, offering services from discovery through clinical application.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial and Observational Study Management Service unit that administers Phase I, II and III clinical trials and observational studies, providing administrative, technical and economic advice to researchers, sponsors and CROs across the ibs.GRANADA network.
- Innovation and Technology Transfer Management Service unit that promotes knowledge transfer, supports protection of research results, and manages intellectual property licensing for FIBAO-affiliated researchers and groups.
- Funding Opportunity Management Service that identifies, disseminates and helps researchers secure national and international funding opportunities for R&D+I projects in health, including grants, fellowships, prizes and project funding.
- Methodological and Statistical Support Specialized statistical and methodological support services for biomedical research projects, delivered across multiple locations including Granada, Jaén and Almería.
- Research Human Resources Services HR management services for research staff including publication of job offers, coordination of training actions, and career development support across the ibs.GRANADA network.
- Economic-Administrative Advisory and Management Economic and administrative advisory services for management of scientific activity, including expense reimbursement and financial planning for research projects.
- Agreements and Donations Management Management of private financing agreements and donations directed to research, ensuring proper governance, compliance and traceability of funds.
- Research Communication and Promotion Scientific communication and research promotion services, including news dissemination, event organization and visibility for ibs.GRANADA research groups and their outputs.
- Quality and Knowledge Management Knowledge management unit for ibs.GRANADA research groups, supporting research quality assurance and structured knowledge transfer within the network.
- Technology Transfer Catalog (Ofertas Tecnológicas) Catalog of protected research results including medical devices (e.g., TClamp, urinary catheter three-way valve), diagnostic methods (e.g., EPIMETRIC for COPD, GenHUSC pharmacogenetic interpretation, ML-based headache diagnosis), therapies (e.g., antitumor gene therapy, nanobodies against HSV-1/HSV-2/VZV) and ICT solutions, made available for licensing to companies.
- Funding Opportunities Portal (Convocatorias) Online portal listing 341 national and international funding calls for research, including grants, fellowships, prizes and project funding across health research areas.
- Employment Opportunities Portal (Ofertas de Empleo) Online portal listing job openings for research and technical positions across FIBAO's network of hospitals and research institutions.
- GMP Advanced Therapy Medicinal Products Manufacturing Facility Authorized GMP (Good Manufacturing Practice) clean-room facility for manufacturing advanced therapy medicinal products (ATMPs) using cell or tissue-based material from patients or donors; part of the ibs.GRANADA research infrastructure hosting the Andalusian network of certified advanced therapy laboratories.
- Early Phase Clinical Trials Unit Early Phase Clinical Trials Unit developing 80 projects with the objective of offering patients early, equitable and safe access to the most innovative therapies; hosted at Hospital Universitario Virgen de las Nieves.
Quantifiable outcome
- 200+ clinical trials managed annually
- +6 more outcomes
Companies that use FIBAO
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles3 records
FIBAO technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature4 records
FIBAO partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- ibs.GRANADA (Instituto de Investigación Biosanitaria de Granada)coreFIBAO manages ibs.GRANADA, the only ISCIII-accredited biomedical research institute in Granada and one of five in Andalusia. The institute integrates over 1,215 researchers and 75 research groups from Universidad de Granada, Hospital Universitario Virgen de las Nieves, Hospital Universitario Clínico San Cecilio, Escuela Andaluza de Salud Pública, and primary care centers. Research output includes 1,154 publications annually and 19 patents filed.
- Universidad de GranadacoreUniversity partner providing research groups to ibs.GRANADA. Collaboration in research projects, doctoral programs, and knowledge transfer. The university contributes faculty members to research activities and provides academic infrastructure.
- Universidad de AlmeríacoreUniversity partner contributing research groups to the FIBAO network, particularly in Almería region. Supports research activities and provides academic expertise.
- Universidad de JaéncoreUniversity partner contributing research groups and collaborating in joint scientific events with Hospital Universitario de Jaén. Supports research in health sciences.
- Red de Fundaciones Gestoras de Investigación del SSPAcoreFIBAO is part of the Regional Network of Research Management Foundations of the Andalusian Public Health System, coordinating research management across Andalusia.
- Red Andaluza de Diseño y Traslación de Terapias AvanzadascoreRegional network coordinated by Fundación Pública Andaluza Progreso Salud that advances design and translation of advanced therapies in Andalusia.
- Servicio Andaluz de Salud (SAS)coreRegional health service providing the institutional framework for FIBAO operations. SAS owns the 6 certified advanced therapy laboratories and supports research infrastructure.
- Junta de Andalucía - Consejería de SaludcoreRegional government health authority providing funding and strategic direction. Has funded programs including 21.94 million euros for youth research employment (299 contracts) and supports healthcare innovation initiatives.
- Various pharmaceutical and biotech companiesminorCompanies interested in licensing protected research results including medical devices, diagnostics, therapies, and ICT solutions from FIBAO's technology portfolio.
- Instituto de Salud Carlos III (ISCIII)coreNational health research institute that provides ISCIII accreditation to ibs.GRANADA and funds research projects through national R&D+i calls.
- Escuela Andaluza de Salud PúblicacoreAndalusian School of Public Health integrated in ibs.GRANADA, contributing public health research expertise and training capabilities.
Scale indicators16 records
Recent moves6 records
Expansion highlights6 records
FIBAO competitors and assessment
Company assessmentDirect peers
- Fundación Progreso y Salud: Foundation managing biomedical research in the Andalusian Public Health System alongside FIBAO. Both belong to the Red de Fundaciones Gestoras de Investigación del SSPA and operate analogous clinical-trial, innovation-transfer, and methodological-support service portfolios across different Andalusian provinces.
- IDIBAPS — Institut d'Investigacions Biomèdiques August Pi i Sunyer: ISCIII-accredited biomedical research institute in Barcelona affiliated with Hospital Clínic and the University of Barcelona. Comparable in operating model (hospital-university research institute managing clinical trials, innovation transfer, and GMP capacity) and accreditation status, though in a different region.
- VHIO — Vall d'Hebron Institute of Oncology: ISCIII-accredited research institute in Barcelona focused on translational oncology, with its own early-phase clinical trials unit and pharma partnership pipeline. Comparable to FIBAO's GMP and early-phase trial infrastructure at ibs.GRANADA, though with a narrower disease focus.
- IIS-FJD — Instituto de Investigación Sanitaria Fundación Jiménez Díaz: ISCIII-accredited biomedical research institute in Madrid managing clinical trials, methodological support, and innovation transfer for the Jiménez Díaz hospital network. Highly comparable structure to FIBAO as a hospital-network-anchored research management foundation.
- IIS La Fe — Instituto de Investigación Sanitaria La Fe: ISCIII-accredited research institute in Valencia, integrated with Hospital Universitari i Politècnic La Fe. Operates clinical trial management, advanced therapies, and innovation-transfer services analogous to FIBAO's portfolio.
Regional players
- IBIMA — Instituto de Investigación Biomédica de Málaga: ISCIII-accredited biomedical research institute in Málaga, also part of the Andalusian research ecosystem. Operates a comparable hospital-university research management model but serves Western Andalusia rather than FIBAO's Eastern Andalusia territory.
- INIBICA — Instituto de Investigación e Innovación Biomédica de Cádiz: ISCIII-accredited biomedical research institute in Cádiz, integrated with Hospital Universitario Puerta del Mar. Same Andalusian regional network as FIBAO but serving a different provincial catchment.
- IdISBa — Institut d'Investigació Sanitària Illes Balears: ISCIII-accredited biomedical research institute in the Balearic Islands operating a hospital-university research management model. Comparable structure and service mix to FIBAO but serves a different Spanish regional catchment.
Broad incumbents
- CIBER — Centro de Investigación Biomédica en Red: National consortium of biomedical research groups funded by ISCIII across Spain. Functions as a broader umbrella network that many ISCIII-accredited institutes (including FIBAO's ibs.GRANADA) participate in, with overlapping thematic areas but a wider national scope.
- CNIO — Centro Nacional de Investigaciones Oncológicas: Spain's national cancer research centre in Madrid, funded by ISCIII. Comparable in advanced therapy and translational research capabilities but operates as a national-level, cancer-specialized institution rather than a regional multi-hospital research foundation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
FIBAO social profiles
Digital presenceFIBAO financial estimates
Financial estimateRevenue estimate
Valuation estimate
FIBAO leadership team
Management profileNumber of profiles
Profiles1 record
FIBAO funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FIBAO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FIBAO
What does FIBAO do?
FIBAO provides integral management of biomedical research across Eastern Andalusia, delivering services that span the full research value chain from discovery to clinical application. Its core offerings include clinical trial and observational study management, innovation and technology transfer, funding opportunity management, methodological and statistical support, HR and economic-administrative administration for researchers, plus specialized GMP infrastructure for advanced therapy medicinal products and an Early Phase Clinical Trials Unit.
Is FIBAO a public or private company?
FIBAO is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was FIBAO founded?
FIBAO was founded in 2006. It employs 101 to 250 people.
Where is FIBAO based?
FIBAO is headquartered in Granada, Nicaragua, in the Latin America region.
How does FIBAO make money?
Four revenue lines are on record. Public funding and grants are the primary driver. The others are european Social Fund Plus (FSE+) co-financing, innovation transfer and licensing and clinical trial management services.
Who are FIBAO's main competitors?
Direct peers on record are Fundación Progreso y Salud, IDIBAPS — Institut d'Investigacions Biomèdiques August Pi i Sunyer, VHIO — Vall d'Hebron Institute of Oncology, IIS-FJD — Instituto de Investigación Sanitaria Fundación Jiménez Díaz and IIS La Fe — Instituto de Investigación Sanitaria La Fe. Regional players are IBIMA — Instituto de Investigación Biomédica de Málaga, INIBICA — Instituto de Investigación e Innovación Biomédica de Cádiz and IdISBa — Institut d'Investigació Sanitària Illes Balears. Broad incumbents are CIBER — Centro de Investigación Biomédica en Red and CNIO — Centro Nacional de Investigaciones Oncológicas.
Does FIBAO have an API?
No public API is recorded for FIBAO.
What industry is FIBAO in?
FIBAO's product category is Biomedical Research Management Services. Its primary akta.pro industry code is BPAHALAE, Industry & Sector Research (Syndicated/Custom). Its NAICS code is 5417 and its SIC code is 8731.